Chen K R, Su W P, Pittelkow M R, Conn D L, George T, Leiferman K M
Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA.
J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):173-82. doi: 10.1016/s0190-9622(96)90318-7.
Neutrophilic and lymphocytic vascular inflammation is common in vasculitis associated with connective tissue disease (CTD). We recently identified eight patients with CTD and eosinophilic vasculitis.
The purpose of this study was to characterize a variant form of vasculitis in CTD with eosinophilic infiltration.
Of 98 CTD patients with cutaneous necrotizing vasculitis, eight were found with predominantly eosinophilic vascular infiltration. Nine CTD patients with cutaneous neutrophilic vasculitis were identified for comparison. Clinical and laboratory findings were reviewed and compared. Indirect immunofluorescence for eosinophil granule major basic protein (MBP), neutrophil elastase, and mast cell tryptase was performed on lesional tissue. MBP levels and eosinophil survival enhancing activity were assayed in sera from three patients.
The patients with eosinophilic vasculitis had depressed serum complement levels and peripheral blood eosinophilia; MBP levels were elevated in serum and eosinophil survival was prolonged. Immunofluorescence of tissue showed marked angiocentric eosinophil MBP staining with peripheral neutrophil elastase staining; mast cell tryptase staining was notably absent. The patients with neutrophilic vasculitis were variably hypocomplementemic and did not have peripheral blood eosinophilia. Immunofluorescence showed marked angiocentric neutrophil elastase staining with scattered eosinophil MBP staining; mast cell tryptase staining showed normal mast cell numbers.
Patients with eosinophilic vasculitis, CTD, and hypocomplementemia show vessel wall destruction in association with vessel wall deposition of cytotoxic eosinophil granule MBP, which suggests that eosinophils mediate vascular damage in this disease process. In addition, perivascular mast cells appear diminished, thereby suggesting that mast cell degranulation occurs.
嗜中性粒细胞和淋巴细胞性血管炎症在结缔组织病(CTD)相关的血管炎中很常见。我们最近发现了8例患有CTD和嗜酸性粒细胞性血管炎的患者。
本研究的目的是对CTD中伴有嗜酸性粒细胞浸润的一种血管炎变异形式进行特征描述。
在98例患有皮肤坏死性血管炎的CTD患者中,发现8例主要为嗜酸性粒细胞血管浸润。另外确定了9例患有皮肤嗜中性粒细胞血管炎的CTD患者作为对照。回顾并比较了临床和实验室检查结果。对病变组织进行了嗜酸性粒细胞颗粒主要碱性蛋白(MBP)、中性粒细胞弹性蛋白酶和肥大细胞类胰蛋白酶的间接免疫荧光检测。对3例患者的血清进行了MBP水平和嗜酸性粒细胞存活增强活性检测。
嗜酸性粒细胞性血管炎患者血清补体水平降低,外周血嗜酸性粒细胞增多;血清中MBP水平升高,嗜酸性粒细胞存活时间延长。组织免疫荧光显示明显的血管中心性嗜酸性粒细胞MBP染色,外周有中性粒细胞弹性蛋白酶染色;肥大细胞类胰蛋白酶染色明显缺失。嗜中性粒细胞性血管炎患者补体水平不同程度降低,外周血无嗜酸性粒细胞增多。免疫荧光显示明显的血管中心性中性粒细胞弹性蛋白酶染色,伴有散在的嗜酸性粒细胞MBP染色;肥大细胞类胰蛋白酶染色显示肥大细胞数量正常。
嗜酸性粒细胞性血管炎、CTD和低补体血症患者显示血管壁破坏,伴有细胞毒性嗜酸性粒细胞颗粒MBP在血管壁沉积,这表明嗜酸性粒细胞在该疾病过程中介导血管损伤。此外,血管周围肥大细胞似乎减少,从而提示肥大细胞脱颗粒发生。